Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Junru Ye

Responses to Crizotinib and Chemotherapy in Patients With Lung Adenocarcinoma Harboring a Concomitant EGFR Mutation and ALK Gene Rearrangement: A Case Report and Review of the Literature

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Related publications

A Heterochronic Genetic Change From an EGFR Mutation to an ALK Rearrangement in a Patient With Lung Adenocarcinoma: A Case Report

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

P1.01-30 Crizotinib in Advanced Non-Adenocarcinoma, NSCLC (NA-NSCLC) Patients With ALK Rearrangement: A Retrospective Study and Literature Review

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Adenocarcinoma of the Lung With EGFR Gene Mutation and Subsequent Resistance Mechanisms Exploration: Case Report

OncoTargets and Therapy
OncologyPharmacology
2017English

Chemotherapy Combined With Bevacizumab for the Treatment of Advanced Lung Adenocarcinoma Cancer Harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 Mutations: A Case Report

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Concurrent Presence of ALK Rearrangement and MET Mutation in Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Patients Harboring EGFR Mutation After Primary Resistance to Crizotinib and Response to EGFR-tyrosine Kinase Inhibitor

OncoTargets and Therapy
OncologyPharmacology
2016English

P3.13-16 Concomitant EML4-ALK Rearrangement and EGFR Mutation in Non-Small Cell Lung Cancer Patients: Data From Eastern Indian Hospital.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.01-29 Crizotinib in Advanced Lung Adenocarcinoma Patients With ALK or ROS-1 Rearrangement: Is It the Same?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy